StrokeDx Raises Oversubscribed $5 Million Seed Prime Round to Advance Next-Generation Stroke Technology
Summary
The oversubscribed round was led by DigiTx Partners, with participation by Freeflow Ventures and other existing investors with extensive accomplishments across neuroradiology, stroke, and medical devices. To date, StrokeDxs technology has raised almost $10 million, including a National Institutes of Health (NIH) R01 Grant. By utilizing portable devices, StrokeDx addresses critical issues in healthcare accessibility and equity. Early intervention can significantly reduce the impact of stroke, shifting the focus from treatment to prevention, said Alexander Ballatori, Co-Founder and CEO of StrokeDx.We believe in the potential of StrokeDxs technology to change the diagnostic paradigm and ultimately improve outcomes for stroke patients. By providing accessible, advanced technology, we can reach millions of at-risk individuals, potentially saving countless lives and reducing the burden on healthcare systems around the world, said David J. Kim, MD, Managing Director of DigiTx Partners.About StrokeDx: StrokeDx is at the forefront of developing next-generation stroke detection technology.